|
⚲
|
| Biotechnology Value Fund L P | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000918923 |
| Sale | 2008-09-01 ($29.2 M Sold) |
| Fund | |
| Phone | 3125066500 |
| Address | 900 N Michigan Avenue, Suite 1100 Chicago, 60611 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Mark Lampert | |
| Matthew Perry | |
| Oleg Nodelman | |
| BVF Inc | |
| BVF Partners LP |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Contrarian Opportunity Fund III Offshore, L.P.
✚
|
0.0 | |
|
Contrarian Thinking Capital I, a series of Contrarian Thinki
✚
|
0.0 | |
|
Contrarian Valdis Fund, L.P.
✚
|
0.0 | |
|
Control Mobile Inc.
✚
|
0.0 | |
|
ControlRad, Inc.
✚
|
0.0 | |
|
Controneo Pat
✚
|
0.0 | |
|
Convective Capital Fund I, L.P.
✚
|
0.0 | |
|
Conversion Capital Fund, LP
✚
|
0.0 | |
|
Conversion Innovations Inc
✚
|
0.0 | |
|
Contrarian Opportunity Fund III, L.P.
✚
|
0.0 |